Monday, February 16, 2026 2/16/2026

Lipid signaling in cardiac development and disease

Award Number: K01HL135464
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP
PERIOD OF PERFORMANCE START DATE: 12/15/2016
PERIOD OF PERFORMANCE END DATE: 11/30/2022

Group Awards By:

View Award Description

Lipid signaling in cardiac development and disease - PROJECT SUMMARY This proposal contains a detailed five-year training program for mentored career development of a underrepresented minority in biomedical research, with a focus on cardiovascular disease and lipid signaling. The Applicant has completed training in cardiovascular development and stem cell biology and is proposing a research direction specifically designed to provide additional essential training for his transition towards an independent academic research career. Through the career and scientific plans contained in this proposal, the Applicant aims to leverage his prior training in stem cell biology and cardiac development, with newly acquired skills in mass spectrometry-based lipidomics, large-dataset analysis, high-content screening and cardiovascular disease models within a well-structured and mentored scientific environment, in order to understand the eicosanoid changes that occur in cardiomyocytes during heart development and disease. A joint mentorship has been established between Dr. Mohit Jain, an expert physician-scientist at the University of California San Diego with expertise in metabolomics, systems analysis and genomics, and Dr. Ju Chen, a world expert in stem cell biology, cardiac physiology and disease, to foster the Applicant's scientific and career development. Dr. Jain's and Dr. Chen's laboratories will provide an excellent environment for the applicant, with state-of-the-art infrastructure, analytical skills and innumerable resources required to obtain the necessary training. Both Dr. Jain and Dr. Chen have a proven track record of mentorship, including young investigators transitioning to faculty positions or as independent researchers. The Applicant has put together an expert academic advisory committee of distinguished scientists and clinicians from UCSD and external research communities to guide and complement each other's scientific expertise. Furthermore, the Applicant has also enlisted the advisory support of Dr. Mark Lawson, from UCSD, for training in equity and integration of minorities underrepresented in biomedical sciences. The central goals of this proposal are to 1) investigate activation of the eicosanoid pathway during cardiac stem cell differentiation and heart development, 2) identify specific eicosanoid species that drive cardiomyocyte differentiation, and 3) explore the contribution of eicosanoid signaling pathways in heart failure. The Applicant will utilize an innovative mass spectrometry- based eicosanoid profiling platform, together with in vitro high-content analysis tools, systems analysis, state- of-the art stem cell differentiation techniques and in vivo mouse models of heart development and cardiac disease. These aims will serve to integrate discovery approaches and hypothesis-driven research. The experience obtained from the proposed training and career development will serve as the basis for the Applicant's independent career as scientist.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	MICHIGAN STATE UNIVERSITY	426 AUDITORIUM RD RM 2	EAST LANSING	MI	48824	INGHAM	USA	Cardiovascular Diseases Research	000	6	9/22/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $154,646 )
2021	2021	MICHIGAN STATE UNIVERSITY	426 AUDITORIUM RD RM 2	EAST LANSING	MI	48824	INGHAM	USA	Cardiovascular Diseases Research	000	6	1/14/2021	NON-COMPETING CONTINUATION	$154,646
														Subtotal = $154,646

Issue Date FY: 2020 ( Subtotal = $158,295 )
2020	2020	MICHIGAN STATE UNIVERSITY	426 AUDITORIUM RD RM 2	EAST LANSING	MI	48824	INGHAM	USA	Cardiovascular Diseases Research	000	5	1/1/2020	NON-COMPETING CONTINUATION	$158,295
														Subtotal = $158,295

Issue Date FY: 2019 ( Subtotal = $162,096 )
2019	2019	MICHIGAN STATE UNIVERSITY	426 AUDITORIUM RD RM 2	EAST LANSING	MI	48824	INGHAM	USA	Cardiovascular Diseases Research	000	4	12/13/2018	NON-COMPETING CONTINUATION	$162,096
														Subtotal = $162,096

Issue Date FY: 2018 ( Subtotal = $138,155 )
2018	2018	MICHIGAN STATE UNIVERSITY	426 AUDITORIUM RD RM 2	EAST LANSING	MI	48824	INGHAM	USA	Cardiovascular Diseases Research	004	3	7/30/2018	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$5,709
2018	2018	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR DEPT 621	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	001	2	7/20/2018	NON-COMPETING CONTINUATION	-$167,293
2018	2018	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR DEPT 621	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	000	2	12/5/2017	NON-COMPETING CONTINUATION	$181,516
2018	2018	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR DEPT 621	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	003	2	7/30/2018	NON-COMPETING CONTINUATION	-$5,709
2018	2018	MICHIGAN STATE UNIVERSITY	426 AUDITORIUM RD RM 2	EAST LANSING	MI	48824	INGHAM	USA	Cardiovascular Diseases Research	002	3	7/20/2018	CHANGE OF GRANTEE / TRAINING INSTITUTION / AWARDING INSTITUTION	$123,932
														Subtotal = $138,155

Issue Date FY: 2017 ( Subtotal = $181,516 )
2017	2017	UNIVERSITY OF CALIFORNIA, SAN DIEGO	9500 GILMAN DR DEPT 621	LA JOLLA	CA	92093	SAN DIEGO	USA	Cardiovascular Diseases Research	000	1	12/15/2016	NEW	$181,516
														Subtotal = $181,516

Grand Total All Awards = $794,708

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Lipid signaling in cardiac development and disease

Award Number: K01HL135464

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: TRAINING/TRAINEESHIP

PERIOD OF PERFORMANCE START DATE: 12/15/2016

PERIOD OF PERFORMANCE END DATE: 11/30/2022

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer